Thank you, David. Since you have the financial results beginning on Slide 7, I will just go over the highlights. To help you understand the results we'll be referring mainly to non-GAAP numbers, which exclude share based compensation. Revenues for the quarter were $4.8 million, unchanged from the second quarter but down from last year. As David said, this reflects the focus of the entire organization on our new opportunities. Nevertheless, our bookings for the quarter were at the record level. There is still a lot of potential with our existing customers. For the nine month period, revenues were $16 million, down slightly from $16.4 million in the first nine months of 2014. Turning to Slide 8. Our gross margin for the quarter has set a new record 82.5%. This is in line with the new long term target that we set last quarter which is above 80%. In fact, for the nine months period, gross margin was exactly 80%. As you can see on Slide 9, our gross R&D for the quarter was just under $1.3 million, unchanged from last year. However the net figure is nearly 40% lower for $114,000 compared with $644,000 in the third quarter of 2014. The $867,000 was a catch up grant which we are expecting to receive from the chief scientist for Q1 and Q2 as was communicated in our previous calls this year. For the nine month period, net R&D was $3 million, basically the same for the first nine months of 2014. We expect to continue receiving the R&D grants in the future as we did in the past. But we can never predict the timing. Sales and marketing for the quarter was $2.1 million, up from $1.6 million in the third quarter of 2014. This reflects the commissions paid in respect of the high level of bookings that were recorded during this quarter. For the nine month period, sales and marketing totaled $5.5 million, unchanged from 2014. On Slide 10, you will see that high gross margin plus chief scientist grants made up the most of the revenue shortfall giving us nearly $1 million in operating income on a non-GAAP basis. For the nine month period, operating profit was almost doubled its level in 2014, $2.9 million compared with $1.5 million in the first nine months of 2014. Financial expense during the quarter totaled $107,000. As you know, this item fluctuates from quarter to quarter based on currency exchange rates. For the nine months period, financial expenses have totaled $481,000, obviously impacting our net profit. This compares with just $52,000 for the first nine months of 2014. As you can see on Slide 11, net income for the quarter totaled $835,000 on a non-GAAP basis or $0.10 per basic share. This is down slightly from $872,000 or $0.11 per basic share in the third quarter of 2014. Net income for the first nine months was $2.3 million or $0.26 per basic share. This is up from $1.5 million in the first nine months of 2014. On Slide 12, we’ve given you a full non-GAAP income statement for your reference. Turning to the balance sheet. As you can see on Slide 13, our cash and cash equivalents as of the end of the quarter were $8 million, reflecting continuous strong collection and high customer satisfaction. This compares with just $4.5 million at the end of Q3 a year ago. Our inventory levels have decreased from $2.7 million at the end of 2014 to $1.7 million as of September 30. I would like to direct your attention to Slide 14 and 15. That demonstrates the improvement in our key balance sheet ratio over the past two years. I think that this shows the fundamental strengths of our company better than almost anything else we can present. Back to you, David.